Date Range
Date Range
Date Range
Endocyte Announces Phase 3 Vision Trial Design Finalized for. Lu-PSMA-617 Following End of Phase 2 Meeting with the FDA. Watch our technology at work. In 2018, we will be initiating late-phase clinical trials for mCRPC patients and Phase 1 t.
ENCORE Study Investor Conference Call. Delayed at least 20 minutes. ENCORE Study Investor Conference Call. Nellix EVAS FORWARD IDE Data. LUCY Study 30-day Data Reveal. ASCEND Registry Presentation - Charing Cross 2016. Global Registry Podium Charing Cross 2016.
Nieruchomość inwestycyjna w Będzinie na sprzedaż w dniach 7 26 marca 2018 r. Przetarg na sprzedaż mieszkań w Katowicach i Tychach w dniach 7 21 lutego 2018 r. Montaż części ciśnieniowej na nowo budowanej Elektrowni Maasvlakte Power Plant w Holandii.
Intraday data provided by eSignal. EnerNOC Reports Results for Second Quarter of 2015. EnerNOC to Present at Upcoming Investor Conferences. Events and Presentations View all.
Enphase Energy delivers energy management technology for the solar industry that increases energy production, simplifies design and installation, improves system uptime and reliability, reduces fire safety risk and provides a platform for intelligent energy management. Its semiconductor-based microinverter system converts energy at the individual solar module level and brings a system-based high-technology approach to solar energy generation, storage, control and management.
This site requires Adobe Flash Player. Details on upcoming events are not yet available. 60 per Share; Increases 2015 Guidance. The Ensign Group Acquires Two California Assisted Living Facilities. The Ensign Group, Inc. Second Quarter FY15 Earnings Conference Call.